96 related articles for article (PubMed ID: 17191955)
1. Identification of novel neuroprotective agents using pharmacophore modeling.
Faden AI; Movsesyan VA; Fang X; Wang S
Chem Biodivers; 2005 Nov; 2(11):1564-70. PubMed ID: 17191955
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of novel small peptides in vitro and after brain injury.
Faden AI; Movsesyan VA; Knoblach SM; Ahmed F; Cernak I
Neuropharmacology; 2005 Sep; 49(3):410-24. PubMed ID: 15907950
[TBL] [Abstract][Full Text] [Related]
3. Dose-response features of neuroprotective agents: an integrative summary.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(4):253-348. PubMed ID: 18432419
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship studies of 3-substituted indolin-2-ones as effective neuroprotective agents.
Balderamos M; Ankati H; Akubathini SK; Patel AV; Kamila S; Mukherjee C; Wang L; Biehl ER; D'Mello SR
Exp Biol Med (Maywood); 2008 Nov; 233(11):1395-402. PubMed ID: 18957634
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological profile of serofendic acids A and B.
Terauchi T; Asai N; Doko T; Taguchi R; Takenaka O; Sakurai H; Yonaga M; Kimura T; Kajiwara A; Niidome T; Kume T; Akaike A; Sugimoto H
Bioorg Med Chem; 2007 Nov; 15(22):7098-107. PubMed ID: 17804246
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity.
Alonso De Diego SA; Gutiérrez-Rodríguez M; Pérez de Vega MJ; González-Muñiz R; Herranz R; Martín-Martínez M; Cenarruzabeitia E; Frechilla D; Del Río J; Jimeno ML; García-López MT
Bioorg Med Chem Lett; 2006 Jul; 16(13):3396-400. PubMed ID: 16650992
[TBL] [Abstract][Full Text] [Related]
7. Novel polyamine derivatives as neuroprotective agents.
Gilad GM; Gilad VH
J Pharmacol Exp Ther; 1999 Oct; 291(1):39-43. PubMed ID: 10490884
[TBL] [Abstract][Full Text] [Related]
8. A highly sulfated chondroitin sulfate preparation, CS-E, prevents excitatory amino acid-induced neuronal cell death.
Sato Y; Nakanishi K; Tokita Y; Kakizawa H; Ida M; Maeda H; Matsui F; Aono S; Saito A; Kuroda Y; Hayakawa M; Kojima S; Oohira A
J Neurochem; 2008 Mar; 104(6):1565-76. PubMed ID: 17996021
[TBL] [Abstract][Full Text] [Related]
9. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant and neuroprotective properties of N-arachidonoyldopamine.
Bobrov MY; Lizhin AA; Andrianova EL; Gretskaya NM; Frumkina LE; Khaspekov LG; Bezuglov VV
Neurosci Lett; 2008 Jan; 431(1):6-11. PubMed ID: 18069125
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on beta-amyloid peptide neurotoxicity.
Ho YS; Yu MS; Lai CS; So KF; Yuen WH; Chang RC
Brain Res; 2007 Jul; 1158():123-34. PubMed ID: 17568570
[TBL] [Abstract][Full Text] [Related]
12. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.
Nangaku M; Izuhara Y; Takizawa S; Yamashita T; Fujii-Kuriyama Y; Ohneda O; Yamamoto M; van Ypersele de Strihou C; Hirayama N; Miyata T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2548-54. PubMed ID: 17932321
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological enhancement of neuronal survival.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(4):349-89. PubMed ID: 18432420
[TBL] [Abstract][Full Text] [Related]
14. Potential neuroprotective drugs in cerebral ischemia: new saturated and polyunsaturated lipids coupled to hydrophilic moieties: synthesis and biological activity.
Biraboneye AC; Madonna S; Laras Y; Krantic S; Maher P; Kraus JL
J Med Chem; 2009 Jul; 52(14):4358-69. PubMed ID: 19537799
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture.
Limpeanchob N; Jaipan S; Rattanakaruna S; Phrompittayarat W; Ingkaninan K
J Ethnopharmacol; 2008 Oct; 120(1):112-7. PubMed ID: 18755259
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of phenylenediamine derivatives independent of an antioxidant pathway in neuronal HT22 cells.
Satoh T; Izumi M
Neurosci Lett; 2007 May; 418(1):102-5. PubMed ID: 17400379
[TBL] [Abstract][Full Text] [Related]
17. Studies of benzamide- and thiol-based histone deacetylase inhibitors in models of oxidative-stress-induced neuronal death: identification of some HDAC3-selective inhibitors.
Chen Y; He R; Chen Y; D'Annibale MA; Langley B; Kozikowski AP
ChemMedChem; 2009 May; 4(5):842-52. PubMed ID: 19350613
[TBL] [Abstract][Full Text] [Related]
18. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo.
Faden AI; Knoblach SM; Cernak I; Fan L; Vink R; Araldi GL; Fricke ST; Roth BL; Kozikowski AP
J Cereb Blood Flow Metab; 2003 Mar; 23(3):342-54. PubMed ID: 12621309
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids.
Chang HJ; Kim HJ; Chun HS
Life Sci; 2007 Feb; 80(9):835-41. PubMed ID: 17166521
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats.
Cadichon SB; Le Hoang M; Wright DA; Curry DJ; Kang U; Frim DM
J Neurosurg; 2007 Jan; 106(1 Suppl):36-40. PubMed ID: 17233310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
